OSCR Oscar Health, Inc.

bearish track record → $16.44 +0.65 (+4.1%)
Get emailed when OSCR changes direction
Mkt Cap $5B 52wk $10.69 - $23.80 Earnings 2026-05-06 47d ago
≠
We disagree with Wall Street. Analyst consensus: bullish. Our position: bearish. See factor model below for why.
Insider buying: $58,040,012 bought by 18 insiders (30d)
Factor divergence: DIVERGENCE: analyst_revisions bullish vs estimate_revisions bearish
Est. revisions: -13.1% (3 up, 1 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net -0.2)

Factor Model

net -0.2 1.3 / 10
Est. Revisions
-0.7
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+0.8
Narrative Gap
+0.0

Longleaf exits after gains; ACA risks mount

Watch: Watch for ACA subsidy changes in the next fiscal year and any shifts in competitor positioning. A subsidy reduction would test whether Oscar's membership growth and cost discipline can offset lower per-member economics.

Oscar Health posted above-market membership growth and expense discipline that caught the attention of Longleaf Partners Small-Cap Fund, which built a position in the stock. The fund exited in Q3 2025 after the bet paid off, but not because fundamentals deteriorated—they locked in gains and grew concerned about policy uncertainty around ACA subsidy expiration. Since the exit, OSCR has fallen 17% over one month and 21% over the past year as of late February 2026.

A sophisticated small-cap fund exit after gains suggests the risk-reward has shifted. Longleaf's concern about ACA policy uncertainty is the real warning—not operational stumbles but regulatory headwinds that could crimp profitability across the entire health insurance sector. The 47 hedge fund portfolios now holding OSCR by Q4 2025 show other sophisticated investors haven't fled, but Longleaf's cautious tone flags that near-term visibility is murky.

Our Trades

Full track record →
+10.7%

Long Call · Wide Runner

7d held
2026-04-13
+6.3%

Long Call · Risk Manager

3d held
2026-04-10
+7.4%

Long Call · The Indexer

3d held
2026-04-09

Evidence

1d ago Jefferies up OSCR: Underperform → Hold
8d ago Insider buy by THRIVE PARTNERS VII GROWTH GP, L.L.C. (OSCR): $14,429,982
8d ago Insider buy by KUSHNER JOSHUA (OSCR): $14,429,982
8d ago Insider buy by THRIVE PARTNERS VII GROWTH GP, L.L.C. (OSCR): $5,444,343
8d ago Insider buy by KUSHNER JOSHUA (OSCR): $5,444,343
8d ago Insider buy by THRIVE PARTNERS VII GROWTH GP, L.L.C. (OSCR): $3,185,681
8d ago Insider buy by KUSHNER JOSHUA (OSCR): $3,185,681
8d ago Insider buy by BERTOLINI MARK T (OSCR): $11,920,000
6 older signals
12d ago Did Oscar Health’s CEO Just Cast a $12 Million Vote of Confidence?
17d ago Is This Healthcare Stock Undervalued Relative to Its Growth Potential?
39d ago Raymond James Upgrades Oscar Health, Inc. (OSCR), UBS Lowers PT
44d ago Oscar Health’s CEO Says 2026 Is the Year It Finally Turns a Profit — Here’s What He’s Betting On
47d ago Longleaf Partners Small-Cap Fund’s Investment in Oscar Health (OSCR) Paid Off
55d ago Longleaf Partners Small-Cap Fund’s Investment in Oscar Health (OSCR) Paid Off
Fundamentals & Data ▾
Oscar Health, Inc. Healthcare · Healthcare Plans
Mkt Cap
$5B
Beta
1.93
52w Range
$10.69 - $23.80
Short Interest
26.5M 11.06%
Days to Cover
3.9 +3%
Technicals downtrend
from 52w Hi
0.0%
1w return
+6.2%
Insiders
selling 6B / 9S
Analysts
bullish 1 up / 0 down
EPS Estimate
$1.05 -13.1% 30d 3up / 1dn
Est. Dispersion
142% 6 analysts
Analyst Target
$16 $10 - $23
Options P/C
0.59 2C / 0P unusual
Insider Cluster
strong buy 3B / 9S (officer)
Fund Convergence
strong Citadel, Two Sigma, D.E. Shaw, Renaissance
Financials
Revenue
$2.8B +17% YoY
FCF
$663M
Momentum: decelerating
Top Holders
Citadel $113M
Two Sigma $36M
D.E. Shaw $5M
Renaissance $4M
Recent Filings & Data
insider trade 102
net buying · $35,150,212 sold · $58,040,012 bought
18 insiders · 102 transactions (30d)
Recent transactions
WOLIN STEVEN · sell · $348,914
QUANE ALESSANDREA C · other
BERTOLINI MARK T · buy · $11,920,000
BERTOLINI MARK T · other
BLACKLEY RICHARD SCOTT · other
BERTOLINI MARK T · award
SCHLOSSER MARIO T · other
BLACKLEY RICHARD SCOTT · award
BLACKLEY RICHARD SCOTT · sell · $257,369
MCANANEY ADAM · award
MCANANEY ADAM · sell · $250,527
SCHLOSSER MARIO T · award
SCHLOSSER MARIO T · sell · $325,846
LIANG JANET · award
LIANG JANET · sell · $99,796
BALTRUS VICTORIA · award
BALTRUS VICTORIA · sell · $62,103
SCHLOSSER MARIO T · sell · $406,621
SCHLOSSER MARIO T · other
SCHLOSSER MARIO T · sell · $1,309,124
SCHLOSSER MARIO T · other
SCHLOSSER MARIO T · sell · $3,587,708
SCHLOSSER MARIO T · other
SCHLOSSER MARIO T · sell · $582,525
BLACKLEY RICHARD SCOTT · sell · $416,990
MCANANEY ADAM · sell · $30,725
SCHLOSSER MARIO T · sell · $397,579
LIANG JANET · sell · $121,737
BALTRUS VICTORIA · sell · $68,832
SCHLOSSER MARIO T · sell · $5,954,764
SCHLOSSER MARIO T · other
SCHLOSSER MARIO T · sell · $7,279,850
BOYD JEFFERY H · award
WITTMAN VANESSA AMES · award
LANG LAURA W · award
SANKARAN SIDDHARTHA · award
PLOUFFE DAVID · award
GASSEN WILLIAM · award
ROBINSON ELBERT O. JR. · sell · $410,750
BERTOLINI MARK T · other
BLACKLEY RICHARD SCOTT · award
MCANANEY ADAM · award
SCHLOSSER MARIO T · award
LIANG JANET · award
BALTRUS VICTORIA · award
MCANANEY ADAM · award
LIANG JANET · award
SANKARAN SIDDHARTHA · other
BLACKLEY RICHARD SCOTT · sell · $483,668
QUANE ALESSANDREA C · sell · $271,293
BLACKLEY RICHARD SCOTT · other
QUANE ALESSANDREA C · other
BLACKLEY RICHARD SCOTT · sell · $456,978
QUANE ALESSANDREA C · sell · $486,191
SCHLOSSER MARIO T · sell · $117,792
BOPITIYA RANMALI WOODY · sell · $346,308
BALTRUS VICTORIA · sell · $146,029
WOLIN STEVEN · sell · $353,955
BLACKLEY RICHARD SCOTT · other
QUANE ALESSANDREA C · other
SCHLOSSER MARIO T · other
BOPITIYA RANMALI WOODY · other
BALTRUS VICTORIA · other
WOLIN STEVEN · other
KUSHNER JOSHUA · buy · $3,185,681
THRIVE PARTNERS VII GROWTH GP, L.L.C. · buy · $3,185,681
ROBINSON ELBERT O. JR. · sell · $426,250
KUSHNER JOSHUA · buy · $5,444,343
THRIVE PARTNERS VII GROWTH GP, L.L.C. · buy · $5,444,343
KUSHNER JOSHUA · buy · $14,429,982
THRIVE PARTNERS VII GROWTH GP, L.L.C. · buy · $14,429,982
BOYD JEFFERY H · exercise · $2,475,446
BLACKLEY RICHARD SCOTT · sell · $511,066
QUANE ALESSANDREA C · sell · $286,489
BLACKLEY RICHARD SCOTT · sell · $2,349,837
QUANE ALESSANDREA C · sell · $2,629,232
SCHLOSSER MARIO T · sell · $108,957
BOPITIYA RANMALI WOODY · sell · $1,232,364
BALTRUS VICTORIA · sell · $143,957
SCHLOSSER MARIO T · other
BLACKLEY RICHARD SCOTT · other
BOPITIYA RANMALI WOODY · other
BALTRUS VICTORIA · other
WOLIN STEVEN · other
BOYD JEFFERY H · award
WITTMAN VANESSA AMES · award
LANG LAURA W · award
BLACKLEY RICHARD SCOTT · sell · $586,969
QUANE ALESSANDREA C · sell · $328,807
ROBINSON ELBERT O. JR. · award
PLOUFFE DAVID · award
GASSEN WILLIAM · award
BLACKLEY RICHARD SCOTT · sell · $479,302
QUANE ALESSANDREA C · sell · $509,955
SCHLOSSER MARIO T · sell · $115,925
BOPITIYA RANMALI WOODY · sell · $342,623
BALTRUS VICTORIA · sell · $153,135
WOLIN STEVEN · sell · $371,370
BLACKLEY RICHARD SCOTT · other
SCHLOSSER MARIO T · other
BOPITIYA RANMALI WOODY · other
BALTRUS VICTORIA · other
analyst rating 1
Jefferies up → Hold 1d ago
ae trade 3
14 signals · latest 1d ago

Get alerted when OSCR changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →